Orphan drug research, what is at stake for industry and health insurance?

被引：0
|
作者：
Noel, Alain
机构：
来源：
ACTUALITES PHARMACEUTIQUES | 2014年 / 53卷 / 535期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [1] Translational Research and the Health Insurance Industry
    Feldman, Arthur M.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2009, 2 (03): : 169 - 169
  • [2] THE PUBLICS STAKE IN HEALTH-INSURANCE
    BECKER, H
    NURSING OUTLOOK, 1958, 6 (07) : 394 - 396
  • [3] The public's stake in health insurance
    Becker, Harry
    NURSING OUTLOOK, 2012, 60 (05) : 305 - 308
  • [4] Orphan drugs: A problem of public health and an economic stake
    Brandissou, S
    Yagoubi, N
    Hasselot, N
    THERAPIE, 1996, 51 (06): : 647 - 653
  • [5] Insurance Companies' Perspectives on the Orphan Drug Pipeline
    Handfield, Robert
    Feldstein, Josh
    AMERICAN HEALTH AND DRUG BENEFITS, 2013, 6 (07): : 589 - 598
  • [6] Risk and Reward in the Orphan Drug Industry
    Lo, Andrew W.
    Thakor, Richard T.
    JOURNAL OF PORTFOLIO MANAGEMENT, 2019, 45 (05): : 30 - 45
  • [7] What Is the Purpose of the Orphan Drug Act?
    Herder, Matthew
    PLOS MEDICINE, 2017, 14 (01):
  • [8] What Is Wrong with Orphan Drug Policies?
    Cote, Andre
    Keating, Bernard
    VALUE IN HEALTH, 2012, 15 (08) : 1185 - 1191
  • [9] THE CONTROVERSY OF RESEARCH - THE STAKE OF INTRODUCING AUTOMATIZATION IN INDUSTRY
    BAYART, D
    BERRY, M
    SOCIOLOGIE DU TRAVAIL, 1984, (04) : 500 - 509
  • [10] Are orphan drug companies the pick of the pharmaceutical industry?
    Thomas Morel
    Cedric Popa
    Steven Simoens
    Nature Reviews Drug Discovery, 2014, 13 : 10 - 10
12345